CD8a Antibody Super Bright 702 67-0088-42 from Thermo Fisher Scientific

Product Specs
ItemCD8a Antibody Super Bright 702
CompanyThermo Fisher Scientific
Price Supplier Page
Catalog Number67-0088-42
Quantity100 Tests
ApplicationsFlow Cytometry
Concentration5 µL/Test
Conjugate/TagSuper Bright™ 702
FormatPBS with BSA and 0.09% sodium azide; pH 7.2
PurityAffinity chromatography
ReactivityHuman
TargetCD8a
IsotypeIgG1 kappa
CloneRPA-T8
HostMouse
Storage Temperature4° C, store in dark, DO NOT FREEZE!
Antibody TypePrimary
NCBI Full Gene NameCD8 subunit beta, CD8 subunit alpha
NCBI Gene AliasesLY3, CD8alpha, CD8beta, Leu2, CD8B1, p32, LEU2, Ly-3, CD8, P37, LYT3
ClonalityMonoclonal
Storage4°C, store in dark, DO NOT FREEZE!

81 Wyman Street

Waltham, MA 02451

United States

Phone: 800-678-5599
Fax: 800-331-2286

(2) Mucosal prime-boost immunization with live murine pneumonia virus-vectored SARS-CoV-2 vaccine is protective in macaquesNature communicationsApril 26, 2024Kaiser JA, Nelson CE, Liu X, Park HS, Matsuoka Y, Luongo C, Santos C, Ahlers LRH, Herbert R, Moore IN, et al.

(3) Immune response induced by standard and fractional doses of 17DD yellow fever vaccineNPJ vaccinesMarch 8, 2024Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, et al.

(4) TCR ligand potency differentially impacts PD-1 inhibitory effects on diverse signaling pathwaysThe Journal of experimental medicineDecember 4, 2023Chan W, Cao YM, Zhao X, Schrom EC, Jia D, Song J, Sibener LV, Dong S, Fernandes RA, Bradfield CJ, et al.

(5) Rethinking IL-1 Antagonism in Respiratory Viral Infections: A Role for IL-1 Signaling in the Development of Antiviral T Cell ImmunityInternational journal of molecular sciencesOctober 30, 2023Van Den Eeckhout B, Ballegeer M, De Clercq J, Burg E, Saelens X, Vandekerckhove L, Gerlo S.

(6) Prostate cancer cells synergistically defend against CD8(+) T cells by secreting exosomal PD-L1Cancer medicineAugust 1, 2023Li D, Zhou X, Xu W, Chen Y, Mu C, Zhao X, Yang T, Wang G, Wei L, Ma B.

(9) PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cellsNature communicationsDecember 12, 2022Li Q, Zhang L, You W, Xu J, Dai J, Hua D, Zhang R, Yao F, Zhou S, Huang W, et al.

(12) Multipeptide stimulated PBMCs generate T(EM)/T(CM) for adoptive cell therapy in multiple myelomaOncotargetSeptember 28, 2021Vardam-Kaur T, Pathangey LB, McCormick DJ, Bergsagel PL, Cohen PA, Gendler SJ.

(13) Severe T cell hyporeactivity in ventilated COVID-19 patients correlates with prolonged virus persistence and poor outcomesNature communicationsMay 21, 2021Renner K, Schwittay T, Chaabane S, Gottschling J, Müller C, Tiefenböck C, Salewski JN, Winter F, Buchtler S, Balam S, et al.

(14) Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson's diseaseNPJ Parkinson's diseaseMay 13, 2021Thome AD, Atassi F, Wang J, Faridar A, Zhao W, Thonhoff JR, Beers DR, Lai EC, Appel SH.

(15) Human endoglin-CD3 bispecific T cell engager antibody induces anti-tumor effect in vivoTheranosticsJanuary 1, 2021Zhong L, Shi W, Gan L, Liu X, Huo Y, Wu P, Zhang Z, Wu T, Peng H, Huang Y, et al.

(18) Preventing ATP Degradation by ASO-Mediated Knockdown of CD39 and CD73 Results in A2aR-Independent Rescue of T Cell ProliferationMolecular therapy. Nucleic acidsSeptember 4, 2020Festag J, Thelemann T, Schell M, Raith S, Michel S, Jaschinski F, Klar R.

(19) A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell ToxicityMolecular therapy oncolyticsJune 26, 2020Hammill JA, Kwiecien JM, Dvorkin-Gheva A, Lau VWC, Baker C, Wu Y, Bezverbnaya K, Aarts C, Heslen CW, Denisova GF, et al.

(20) Intracellular delivery of mRNA to human primary T cells with microfluidic vortex sheddingScientific reportsMarch 1, 2019Jarrell JA, Twite AA, Lau KHWJ, Kashani MN, Lievano AA, Acevedo J, Priest C, Nieva J, Gottlieb D, Pawell RS.

Flow